96 related articles for article (PubMed ID: 25484196)
1. Safety and efficacy of the vibrating capsule, an innovative non-pharmacological treatment modality for chronic constipation.
Ron Y; Halpern Z; Safadi R; Dickman R; Dekel R; Sperber AD
Neurogastroenterol Motil; 2015 Jan; 27(1):99-104. PubMed ID: 25484196
[TBL] [Abstract][Full Text] [Related]
2. A single-center, prospective, double-blind, sham-controlled, randomized study of the effect of a vibrating capsule on colonic transit in patients with chronic constipation.
Nelson AD; Camilleri M; Acosta A; Boldingh A; Busciglio I; Burton D; Ryks M; Zinsmeister AR
Neurogastroenterol Motil; 2017 Jul; 29(7):. PubMed ID: 28177172
[TBL] [Abstract][Full Text] [Related]
3. Effects of the vibrating capsule on colonic circadian rhythm and bowel symptoms in chronic idiopathic constipation.
Rao SSC; Lembo A; Chey WD; Friedenberg K; Quigley EMM
Neurogastroenterol Motil; 2020 Nov; 32(11):e13890. PubMed ID: 32449277
[TBL] [Abstract][Full Text] [Related]
4. Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation.
Rao SSC; Quigley EMM; Chey WD; Sharma A; Lembo AJ
Gastroenterology; 2023 Jun; 164(7):1202-1210.e6. PubMed ID: 36822371
[TBL] [Abstract][Full Text] [Related]
5. Treatment of functional constipation with the Yun-chang capsule: a double-blind, randomized, placebo-controlled, dose-escalation trial.
Jia G; Meng MB; Huang ZW; Qing X; Lei W; Yang XN; Liu SS; Diao JC; Hu SY; Lin BH; Zhang RM
J Gastroenterol Hepatol; 2010 Mar; 25(3):487-93. PubMed ID: 20370727
[TBL] [Abstract][Full Text] [Related]
6. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
Tegaserod Clinical Research Group
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702
[TBL] [Abstract][Full Text] [Related]
7. Vibrating colon-stimulating capsule to treat chronic constipation: A systematic review.
Math PB; Ravi R; Hakami T; Das S; Patel N
J Med Life; 2023 Jul; 16(7):1050-1056. PubMed ID: 37900062
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
Quigley EM; Vandeplassche L; Kerstens R; Ausma J
Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome.
Chapman RW; Stanghellini V; Geraint M; Halphen M
Am J Gastroenterol; 2013 Sep; 108(9):1508-15. PubMed ID: 23835436
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of a New Smartphone-controlled Vibrating Capsule on Defecation in Beagles.
Yu J; Qian YY; He CH; Zhu SG; Zhao AJ; Zhu QQ; Shao CW; Wang TG; Wang Y; Ding GL; Liao Z; Li ZS
Sci Rep; 2017 Jun; 7(1):2841. PubMed ID: 28588191
[TBL] [Abstract][Full Text] [Related]
11. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.
Verne GN; Davis RH; Robinson ME; Gordon JM; Eaker EY; Sninksy CA
Am J Gastroenterol; 2003 May; 98(5):1112-6. PubMed ID: 12809836
[TBL] [Abstract][Full Text] [Related]
13. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
[TBL] [Abstract][Full Text] [Related]
14. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.
Mueller-Lissner S; Kamm MA; Wald A; Hinkel U; Koehler U; Richter E; Bubeck J
Am J Gastroenterol; 2010 Apr; 105(4):897-903. PubMed ID: 20179697
[TBL] [Abstract][Full Text] [Related]
15. Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults.
Medoff J; Katz S; Malik P; Pambianco D; Pruitt R; Poulos J; Rank J; Rose M
Clin Ther; 2004 Sep; 26(9):1479-91. PubMed ID: 15531010
[TBL] [Abstract][Full Text] [Related]
16. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
Dipalma JA; Cleveland MV; McGowan J; Herrera JL
Am J Gastroenterol; 2007 Jul; 102(7):1436-41. PubMed ID: 17403074
[TBL] [Abstract][Full Text] [Related]
17. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
[TBL] [Abstract][Full Text] [Related]
18. Lubiprostone for constipation in adults with cystic fibrosis: a pilot study.
O'Brien CE; Anderson PJ; Stowe CD
Ann Pharmacother; 2011 Sep; 45(9):1061-6. PubMed ID: 21852592
[TBL] [Abstract][Full Text] [Related]
19. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.
Johanson JF; Morton D; Geenen J; Ueno R
Am J Gastroenterol; 2008 Jan; 103(1):170-7. PubMed ID: 17916109
[TBL] [Abstract][Full Text] [Related]
20. [Analysis on follow-up efficacy and safety of slow transit constipation treated with individualized deep puncture at Tianshu (ST 25): a multi-central randomized controlled trial].
Peng WN; Wang L; Liu ZS; Guo J; Cai HJ; Ni JN; Duan JX; Yang DL
Zhongguo Zhen Jiu; 2013 Oct; 33(10):865-9. PubMed ID: 24377211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
